N. Yordam et al., REVIEW OF TURKISH PATIENTS WITH GROWTH-HORMONE INSENSITIVITY (LARON TYPE), European journal of endocrinology, 133(5), 1995, pp. 539-542
Clinical spectrum and endocrine details of thirteen Turkish children (
age 0.3-14.2 years; eight females and five males; ten prepubertal, thr
ee pubertal) with growth hormone insensitivity are presented. All pati
ents display phenotypical features of severe growth hormone deficiency
. The diagnosis based on height standard deviation score (SDS), basal
growth hormone (GK), basal insulin-like growth factor I (IGF-I, IGF-I
response in an IGF generation test and growth hormone binding protein
(GHBP) measurements. The median height SDS was -7.4 (range -3.2 to -10
), weight for height index was 100 (range 81-152) and bone age/height
age ratio was 2 (range 1.6-3.3). Endocrine investigations showed a med
ian basal GH concentration of 61.4 mU/1 (range 23.5-120mU/l). Basal IG
F-I level was below 10 ng/ml in all patients except one. None of the p
atients showed a significant IGF-I response to injections of GH (0.1 U
/kg body weight for 4 days). The median IGFBP-3 level was 0.23 mg/l (r
ange 0.1-0.56 mg/l). The GHBP level was undetectable in all of 10 pati
ents. The high number of patients in our center may be due to the high
rate of consanguinity among the Turkish population and the referral f
acility of our center in the area. These patients may benefit from the
new therapy with recombinant human IGF-I.